BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 20661426)

  • 21. An interaction between hepatocyte growth factor and its receptor (c-MET) prolongs the survival of chronic lymphocytic leukemic cells through STAT3 phosphorylation: a potential role of mesenchymal cells in the disease.
    Giannoni P; Scaglione S; Quarto R; Narcisi R; Parodi M; Balleari E; Barbieri F; Pattarozzi A; Florio T; Ferrini S; Corte G; de Totero D
    Haematologica; 2011 Jul; 96(7):1015-23. PubMed ID: 21486864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia.
    Buchner M; Baer C; Prinz G; Dierks C; Burger M; Zenz T; Stilgenbauer S; Jumaa H; Veelken H; Zirlik K
    Blood; 2010 Jun; 115(22):4497-506. PubMed ID: 20335218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isoform-selective phosphoinositide 3'-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach.
    Niedermeier M; Hennessy BT; Knight ZA; Henneberg M; Hu J; Kurtova AV; Wierda WG; Keating MJ; Shokat KM; Burger JA
    Blood; 2009 May; 113(22):5549-57. PubMed ID: 19318683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guilty bystanders: nurse-like cells as a model of microenvironmental support for leukemic lymphocytes.
    Filip AA; Ciseł B; Wąsik-Szczepanek E
    Clin Exp Med; 2015 Feb; 15(1):73-83. PubMed ID: 24337970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CXCL12 is a costimulator for CD4+ T cell activation and proliferation in chronic lymphocytic leukemia patients.
    Borge M; Nannini PR; Morande PE; Jancic C; Bistmans A; Bezares RF; Giordano M; Gamberale R
    Cancer Immunol Immunother; 2013 Jan; 62(1):113-24. PubMed ID: 22842611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CXCR4 and SDF-1 expression in B-cell chronic lymphocytic leukemia and stage of the disease.
    Barretina J; Juncà J; Llano A; Gutiérrez A; Flores A; Blanco J; Clotet B; Esté JA
    Ann Hematol; 2003 Aug; 82(8):500-505. PubMed ID: 12783211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microenvironment dependency in Chronic Lymphocytic Leukemia: The basis for new targeted therapies.
    ten Hacken E; Burger JA
    Pharmacol Ther; 2014 Dec; 144(3):338-48. PubMed ID: 25050922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy.
    Mousavi A
    Immunol Lett; 2020 Jan; 217():91-115. PubMed ID: 31747563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ZAP-70 promotes the infiltration of malignant B-lymphocytes into the bone marrow by enhancing signaling and migration after CXCR4 stimulation.
    Calpe E; Purroy N; Carpio C; Abrisqueta P; Carabia J; Palacio C; Castellví J; Crespo M; Bosch F
    PLoS One; 2013; 8(12):e81221. PubMed ID: 24312539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1).
    Möhle R; Failenschmid C; Bautz F; Kanz L
    Leukemia; 1999 Dec; 13(12):1954-9. PubMed ID: 10602415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BTK inhibition results in impaired CXCR4 chemokine receptor surface expression, signaling and function in chronic lymphocytic leukemia.
    Chen SS; Chang BY; Chang S; Tong T; Ham S; Sherry B; Burger JA; Rai KR; Chiorazzi N
    Leukemia; 2016 Apr; 30(4):833-43. PubMed ID: 26582643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1.
    Burger JA; Tsukada N; Burger M; Zvaifler NJ; Dell'Aquila M; Kipps TJ
    Blood; 2000 Oct; 96(8):2655-63. PubMed ID: 11023495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AMD3100 reduces CXCR4-mediated survival and metastasis of osteosarcoma by inhibiting JNK and Akt, but not p38 or Erk1/2, pathways in in vitro and mouse experiments.
    Liao YX; Fu ZZ; Zhou CH; Shan LC; Wang ZY; Yin F; Zheng LP; Hua YQ; Cai ZD
    Oncol Rep; 2015 Jul; 34(1):33-42. PubMed ID: 25997540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells.
    Burger JA; Burger M; Kipps TJ
    Blood; 1999 Dec; 94(11):3658-67. PubMed ID: 10572077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative phosphoproteomic analysis reveals system-wide signaling pathways downstream of SDF-1/CXCR4 in breast cancer stem cells.
    Yi T; Zhai B; Yu Y; Kiyotsugu Y; Raschle T; Etzkorn M; Seo HC; Nagiec M; Luna RE; Reinherz EL; Blenis J; Gygi SP; Wagner G
    Proc Natl Acad Sci U S A; 2014 May; 111(21):E2182-90. PubMed ID: 24782546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flt3 ligand and the Flt3 receptor regulate hematopoietic cell migration by modulating the SDF-1alpha(CXCL12)/CXCR4 axis.
    Fukuda S; Broxmeyer HE; Pelus LM
    Blood; 2005 Apr; 105(8):3117-26. PubMed ID: 15618475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis.
    Zhuo W; Jia L; Song N; Lu XA; Ding Y; Wang X; Song X; Fu Y; Luo Y
    Clin Cancer Res; 2012 Oct; 18(19):5387-98. PubMed ID: 22932666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia.
    Cuesta-Mateos C; López-Giral S; Alfonso-Pérez M; de Soria VG; Loscertales J; Guasch-Vidal S; Beltrán AE; Zapata JM; Muñoz-Calleja C
    Exp Hematol; 2010 Sep; 38(9):756-64, 764.e1-4. PubMed ID: 20488224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of CXCL12/CXCR4 signaling axis in pancreatic cancer.
    Wu PF; Lu ZP; Cai BB; Tian L; Zou C; Jiang KR; Miao Y
    Chin Med J (Engl); 2013; 126(17):3371-4. PubMed ID: 24033967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.
    Petlickovski A; Laurenti L; Li X; Marietti S; Chiusolo P; Sica S; Leone G; Efremov DG
    Blood; 2005 Jun; 105(12):4820-7. PubMed ID: 15728130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.